“Johnson & Johnson single dose vaccine offers high protection and works”

Interview with Paul Stoffels, Scientific Director of Johnson & Johnson on the vaccine just approved by the EMA – Laura Cuppini /Courier TV
KEEP READING ”

Johnson & Johnson Scientific Director: «We are confident about the variants. The recall will be possible. Our vaccine was tested in South Africa and proved effective against the variant. With a single dose it offers high protection against death and hospitalization. Double dose studies are now underway “”

.

Facebook
Twitter
LinkedIn
Pinterest
Pocket
WhatsApp

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Recent News

Editor's Pick